Substituted diketopiperazines as oxytocin antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/06 (2006.01) A61K 31/496 (2006.01) A61P 15/06 (2006.01)

Patent

CA 2571529

Compounds of formula (IA) wherein R1 is 2-indanyl, R2 is 1-methylpropyl, R3 is 1-methyl-indazol-5-yl, R4 represents methyl and R5 represents hydrogen or methyl, and pharmaceutically acceptable derivatives thereof are described, as are processes for their preparation, pharmaceutical compositions containing them and their use in medicine, particularly their use as oxytocin antagonists.

Cette invention concerne des composés représentés par la formule (IA), dans laquelle R1 représente 2-indanyle, R2 représente 1-méthylpropyle, R3 représente 1-méthyl-indazol-5-yle, R4 représente méthyle et R5 représente hydrogène ou méthyle, et des dérivés de ceux-ci acceptables sur le plan pharmaceutique, ainsi que des procédés pour leur préparation, des compositions pharmaceutiques les contenants et leur utilisation en médecine, notamment comme antagonistes des oxytocines.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted diketopiperazines as oxytocin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted diketopiperazines as oxytocin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted diketopiperazines as oxytocin antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1982609

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.